Results 161 to 170 of about 676,596 (342)
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Pathogenic variants in KIF1C cause Spastic Paraplegia 58 (SPG58), typically presenting with cerebellar ataxia and spastic paraparesis. We report two unrelated patients with spastic paraparesis, cerebellar ataxia, and tremor. Whole‐exome sequence analysis identified novel homozygous variants in the motor domain of KIF1C (NM_006612.6): c.921G>A (
Akihiko Mitsutake +12 more
wiley +1 more source
Game-Based Learning in Neuroscience [PDF]
S Edwards, E Gantwerker, M Cosimini
openalex +1 more source
Developmental neuroscience [PDF]
Current Opinion in Neurobiology, 2011 Arber, Silvia, Davis, Graeme
openaire +3 more sources
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective This study aims to identify both fluid and neuroimaging biomarkers for CSF1R‐RD that can inform the optimal timing of treatment administration to maximize therapeutic benefit, while also providing sensitive quantitative measurements to monitor disease progression.
Tomasz Chmiela +13 more
wiley +1 more source
Some Considerations Regarding the Problem of Multidimensional Utility [PDF]
The concept of 'utility' is often used in ambiguous ways in economics, from having substantive psychological connotations to being a formal placeholder representing a person's preferences.
Martin Binder
core
Explore Potential in Bridging of Neuroscience and Deep Learning [PDF]
Zhiyi Wei +4 more
openalex +1 more source
Neurosciences mathématiques / Mathematical neuroscience
L’annuaire du Collège de France, 2018 Responsable : Jonathan Touboul Publications del Molino L.C.G., Pakdaman K., Touboul J. et Wainrib G., « The real ginibre ensemble with real eigenvalues », Journal of Statistical Physics, vol. 163, n° 2, 2016, p. 303-323, DOI : 10.1007/s10955-016-1485-0. Freret-Hodara B., Cui Y., Griveau A., Vigier L., Arai Y., Touboul J.
openaire +2 more sources
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source